BX Swiss TOP 30 CHF
1.372,35
PKT
-16,20
PKT
-1,17
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 23.12.05 | UBS kaufen | DZ-Bank | |
| 23.12.05 | UBS kaufen | Weberbank | |
| 23.12.05 | Nestlé | Weberbank | |
| 23.12.05 | Novartis | Weberbank | |
| 23.12.05 | Roche reduzieren | Pacific Continental Sec. | |
| 22.12.05 | UBS halten | Helaba Trust | |
| 22.12.05 | Nestlé | Finanzwoche | |
| 27.12.05 | Roche buy | Jyske Bank | |
| 20.12.05 | Swiss Life kaufen | Bankhaus Lampe | |
| 20.12.05 | Novartis halten | Pacific Continental Sec. | |
| 20.12.05 | Swiss Life hold | M.M. Warburg | |
| 16.12.05 | UBS | DZ-Bank | |
| 16.12.05 | Novartis | DZ-Bank | |
| 16.12.05 | Holcim kaufen | Helaba Trust | |
| 16.12.05 | Novartis halten | National-Bank AG | |
| 20.12.05 | Novartis buy | Jyske Bank | |
| 14.12.05 | Roche verkaufen | Hamburger Sparkasse | |
| 14.12.05 | Lonza halten | Hamburger Sparkasse | |
| 13.12.05 | UBS buy | SRC Research | |
| 09.12.05 | UBS | DZ-Bank | |
| 09.12.05 | Novartis | DZ-Bank | |
| 08.12.05 | UBS equal-weight | Morgan Stanley | |
| 07.12.05 | UBS buy | Merrill Lynch | |
| 02.12.05 | Novartis | DZ-Bank | |
| 02.12.05 | UBS | DZ-Bank | |
| 02.12.05 | Swiss Life overweight | JP Morgan | |
| 01.12.05 | Richemont | Focus Money | |
| 01.12.05 | UBS | Zürcher Kantonalbank | |
| 25.11.05 | Nestlé kaufen | Helaba Trust | |
| 28.11.05 | UBS | DZ-Bank | |
| 28.11.05 | Novartis | DZ-Bank | |
| 29.11.05 | Roche buy | Jyske Bank | |
| 25.11.05 | ABB (Asea Brown Boveri) | Wirtschaftswoche | |
| 24.11.05 | Nestlé akkumulieren | Independent Research | |
| 21.11.05 | UBS | Euro am Sonntag | |
| 18.11.05 | UBS | DZ-Bank | |
| 18.11.05 | Novartis | DZ-Bank | |
| 22.11.05 | Nestlé accumulate | Jyske Bank | |
| 22.11.05 | Roche buy | Jyske Bank | |
| 18.11.05 | Richemont kaufen | National-Bank AG |